Plain-English translation of NCT07449377 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing whether Fibroscan®, a bedside ultrasound device that measures liver stiffness, can help diagnose acute heart failure faster in emergency departments. When the heart isn't pumping well, blood backs up into the liver, making it stiffer. This trial will see if measuring liver stiffness with this device can quickly tell doctors whether your shortness of breath is caused by heart failure.
Current emergency department tests for heart failure—like chest X-rays and blood tests—can be slow and don't always give clear answers. This device could provide a quick, accurate bedside answer in minutes, helping doctors start the right treatment faster when you need it most.
You likely qualify if…
You likely don't qualify if…
If you qualify and agree to participate, a clinician will place a small ultrasound probe on your abdomen to measure how stiff your liver is—a quick, painless test that takes just a few minutes at your bedside. This measurement will be taken as part of your emergency care evaluation, alongside the standard tests doctors already do to figure out what's causing your shortness of breath. The study team will then follow up to see how your diagnosis turned out.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
France